Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felipe Ades

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2013
Lapatinib versus placebo added to paclitaxel in first-line human epidermal growth factor receptor 2-positive metastatic breast cancer: ethical lessons not learned from AfricaFelipe Ades
Ecancermedicalscience|December 31, 2015
WHO, RECIST, and immune-related response criteria: is it time to revisit pembrolizumab results?Felipe Ades, Nise Yamaguchi
Dermatology Research and Practice|January 5, 2012
Targeting the Cellular Signaling: BRAF Inhibition and Beyond for the Treatment of Metastatic Malignant MelanomaFelipe Ades, Otto Metzger-Filho
Ecancermedicalscience|July 11, 2017
The past and future of breast cancer treatment-from the papyrus to individualised treatment approachesFelipe Ades, Konstantinos Tryfonidis, Dimitrios Zardavas
Ecancermedicalscience|December 1, 2016
Phosphoethanolamine and the danger of unproven drugsNoam Pondé, Evandro de Azambuja, Felipe Ades
Expert Review of Anticancer Therapy|October 22, 2013
Clinical practice-changing trials: the HERA study paradigmDimitrios Zardavas, Felipe Ades, Evandro de Azambuja
ESMO Open|November 16, 2016
Threat posed by unproven drugs in medical oncologyNoam Pondé, Felipe Ades, Evandro de Azambuja
Current Opinion in Oncology|March 12, 2014
Anticancer drug development: moving away from the old habitsFelipe Ades, Dimitrios Zardavas, Philippe Aftimos, et al.
Drug Safety|December 6, 2011
Benefit-risk assessment of bevacizumab in the treatment of breast cancerRodrigo Dienstmann, Felipe Ades, Kamal S Saini, et al.
Plos One|January 19, 2018
Prime incision: A minimally invasive approach to breast cancer surgical treatment-A 2 cohort retrospective comparison with conventional breast conserving surgerySilvio Eduardo Bromberg, Patricia Rodrigues Alves de Figueiredo Moraes, Felipe Ades
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2013
Lapatinib versus placebo added to paclitaxel in first-line human epidermal growth factor receptor 2-positive metastatic breast cancer: ethical lessons not learned from AfricaFelipe Ades
Ecancermedicalscience|December 31, 2015
WHO, RECIST, and immune-related response criteria: is it time to revisit pembrolizumab results?Felipe Ades, Nise Yamaguchi
Dermatology Research and Practice|January 5, 2012
Targeting the Cellular Signaling: BRAF Inhibition and Beyond for the Treatment of Metastatic Malignant MelanomaFelipe Ades, Otto Metzger-Filho
Ecancermedicalscience|July 11, 2017
The past and future of breast cancer treatment-from the papyrus to individualised treatment approachesFelipe Ades, Konstantinos Tryfonidis, Dimitrios Zardavas
Ecancermedicalscience|December 1, 2016
Phosphoethanolamine and the danger of unproven drugsNoam Pondé, Evandro de Azambuja, Felipe Ades
Expert Review of Anticancer Therapy|October 22, 2013
Clinical practice-changing trials: the HERA study paradigmDimitrios Zardavas, Felipe Ades, Evandro de Azambuja
ESMO Open|November 16, 2016
Threat posed by unproven drugs in medical oncologyNoam Pondé, Felipe Ades, Evandro de Azambuja
Current Opinion in Oncology|March 12, 2014
Anticancer drug development: moving away from the old habitsFelipe Ades, Dimitrios Zardavas, Philippe Aftimos, et al.
Drug Safety|December 6, 2011
Benefit-risk assessment of bevacizumab in the treatment of breast cancerRodrigo Dienstmann, Felipe Ades, Kamal S Saini, et al.
Plos One|January 19, 2018
Prime incision: A minimally invasive approach to breast cancer surgical treatment-A 2 cohort retrospective comparison with conventional breast conserving surgerySilvio Eduardo Bromberg, Patricia Rodrigues Alves de Figueiredo Moraes, Felipe Ades
Pageof 3